ACIA Aero Leasing Enlists Mark Dunnachie to Bolster Lessor’s Market Position
Aviation Sales & Marketing Veteran to Spearhead Efforts to Expand Lessor’s Footprint, Targeting New Growth Opportunities in Turboprop and Freighter Markets
DUBLIN, Ireland, Sept. 19, 2023 (GLOBE NEWSWIRE) -- ACIA Aero Leasing (“ACIA”), a leading provider of regional aircraft leasing and lease management services and solutions, announced today the addition of Mark Dunnachie to the company’s commercial team as Senior Vice President, Commercial. Dunnachie will lead initiatives to expand the reach of the lessor’s platform, with the goal of targeting significant growth opportunities in the turboprop and freighter markets.
“I am delighted to welcome an executive of Mark’s calibre to our team. With a strong original equipment manufacturer (“OEM”) background and a wealth of experience in managing sales and marketing campaigns in various channels within the industry, Mark will make invaluable contributions to the continuing growth of our platform and opening new markets,” said Mick Mooney, Chief Executive Officer of ACIA Aero Leasing.
Dunnachie’s aviation career spans more than three decades, comprising key executive commercial assignments at leading regional manufacturers ATR, Embraer, and BAE Systems. He joins ACIA from ATR, where he served as Head of Commercial, Europe & North America, overseeing commercial, sales, and primary customer relationships for the region. His previous 17-year-tenure at Embraer involved the roles of Head of Lessor Sales, EMEA, and Managing Director of ECC Leasing, the OEM’s asset management arm, in addition to his latest position of Vice President, Asia Pacific. Prior to Embraer, Dunnachie worked at BAE Systems (“BAE”) in a wide range of executive positions, covering market planning, business development, and sales. He was also actively involved in the joint venture between ATR and BAE, AIR International.
"I am excited to be joining Mick and the team at ACIA. ACIA has already built a strong and highly respected market position, and I look forward to working with the team to secure new market opportunities and grow the geographical footprint, particularly around the turboprop and freighter markets. ACIA’s existing pedigree and reputation for excellence across a wide spectrum of solutions offers clear opportunities for further growth in the regional sector,” commented Mark Dunnachie, ACIA Aero Leasing’s newly appointed Senior Vice President, Commercial.
About ACIA Aero Leasing
ACIA Aero Leasing (“ACIA”), a subsidiary of ACIA Aero Capital (“ACIA Group”), is a leading regional aircraft lessor headquartered in Ireland, with offices located in France, Canada, England, and South Africa. ACIA manages a portfolio of nearly 70 regional passenger and freighter aircraft on lease to operators in more than 21 countries globally. Through our strategic partnerships, ACIA provides airlines with turn-key leasing solutions from dry leasing through to charter operations. www.aciaaeroleasing.com
ACIA media contact: Sophie McAuley, Zeevo Group
+1 334 373 4611 // +44 7921 188870 // smcauley@zeevogroup.com
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration3.10.2023 22:05:00 CEST | Press release
PHAXIAM Therapeutics and Vetophage Announce Strategic ResearchCollaboration Strategic research partnership between PHAXIAM Therapeutics and Vetophage, a biotechnology company specialized in veterinary phage therapy Combining expertise in the research of new phages and phage endolysins that could be applied to human health Exclusive phage and endolysin licensing options in human health for PHAXIAM Therapeutics Lyon (France) and Cambridge (MA, US), October03, 2023 – 10:05pm CEST – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM) and Vetophage, a company specialized in phage therapy applied to animal health, announce the signature of a long-term strategic research partnership to combine their expertise in the research of new phages and phage-derived proteins (endolysins) in the fight against antimicrobial resistance. Vetophage is a Lyon-based biotechnology company founded in 2017. It develops new tools to detect pathogenic bacteria and alternative solutions to antibiotics based on phages an
Kvika banki hf.: TM Insurance to be sold or listed3.10.2023 21:05:43 CEST | Press release
Following a strategic review at Kvika banki hf. ("Kvika" or "the bank"), the board of directors of Kvika has decided to initiate a process for the sale or listing of its insurance subsidiary TM tryggingar hf. ("TM"). The decision is in line with the bank's vision, where emphasis is placed on simplifying the group's operations and strengthening Kvika's traditional banking activities, in accordance with the bank's goal to increase competition and simplify its customers' finances. Following the divestment of TM, Kvika's main operations will be focused on commercial- and investment banking, along with asset management. It is expected that Kvika's capital base will grow significantly following the divestment of TM, enabling the bank to pursue internal growth opportunities across Kvika's business segments. Increased capital will, among other things, enable the bank to strengthen its market position, in both retail and corporate lending, and increase the risk diversification of its loan book.
Policane® Natural Sweetener Found to Have Low Glycemic Index3.10.2023 20:06:38 CEST | Press release
OCALA, Fla., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Policane®, a natural sweetener made from sugar cane juice in a patented process, has been found to have a low glycemic index (GI) in a study by IFP Suisse SA. According to the study Policane® has a GI of 51.7+/- 3.66. The study also found that Policane® had a 42% lower GI than white sugar. In its conclusion, the study recommends for Policane® a low glycaemic index product classification under International Standard ISO26642. “We are excited to share the results of this study, providing that Policane® is a low-GI sweetener,” said Jorge Enrique Gonzalez, Manager and CEO at PoliCane Co., LLC. “Policane® retains the best parts of the sugar cane stripped away in refined sugar. Policane® is a natural and sustainable sweetener that the world needs.” Policane® is currently produced under license in Costa Rica and can be used in recipes for all sweetened food and beverages, including baked goods, coffee, tea, colas, sauces, ketchup and desserts. Fo
Nokia Corporation: Repurchase of own shares on 03.10.20233.10.2023 20:00:00 CEST | Press release
Nokia Corporation Stock Exchange Release 3 October 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 03.10.2023 Espoo, Finland – On 3 October 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL344,5423.53CEUX39,5413.54AQEU1,3923.53TQEX14,5253.55Total400,0003.53 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 January 2023
Adevinta ASA – Procedures established in response to receipt of non-binding indicative proposal3.10.2023 19:30:00 CEST | Press release
Oslo, 3 October 2023 – Adevinta ASA (“Adevinta” or the “Company”) refers to the stock exchange announcement on 21 September 2023 regarding receipt of a non-binding indicative proposal (the “Proposal”) from a consortium led by Permira and Blackstone, with involvement of the Company’s two main shareholders, regarding a potential offer for all shares of the Company. In response to shareholder enquiries, the Company wants to communicate the procedures it is following in response to the Proposal. Immediately upon receipt of the Proposal, the Company’s board of directors established a special committee comprising the five independent directors on the Company’s board. The special committee is representing the Company in all aspects relating to the Proposal. The directors who are representatives of the three main shareholders of the Company are not involved in the Company’s deliberations and decisions. The independent committee is actively engaging in the Proposal in line with applicable regul